Re: Dutasteride plus Tamsulosin Fixed-Dose Combination First-Line Therapy versus Tamsulosin Monotherapy in the Treatment of Benign Prostatic Hyperplasia: A Budget Impact Analysis in the Greek Healthcare Setting Editorial Comment

被引：0

作者：

Kashyap, M. ^{[1
]}

Belleville, S. ^{[1
]}

Mulsant, B. H. ^{[1
]}

Hilmer, S. Nl ^{[1
]}

Paquette, A. ^{[1
]}

Tu, L. M. ^{[1
]}

Tannenbaum, C. ^{[1
]}

机构：

[1] Univ Montreal, Inst Univ Geriatrie Montreal, Ctr Rech, Montreal, PQ, Canada

来源：

JOURNAL OF UROLOGY | 2015年 / 194卷 / 05期

关键词：

D O I：

10.1016/j.juro.2015.08.036

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1354 / 1355

页数：2

共 42 条

[21] COST-EFFECTIVENESS OF A FIXED-DOSE COMBINATION OF SOLIFENACIN PLUS TAMSULOSIN OCAS FOR THE TREATMENT OF LOWER URINARY TRACT SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA IN SPAIN
Toledo, A.
Llopis, A.
Mora, A.
Rubio-Torres, C.
Rubio-Rodriguez, D.
Nazir, J.
VALUE IN HEALTH, 2015, 18 (07) : A510 - A510
[22] Re: Comparison of Tamsulosin plus Serenoa repens with Tamsulosin in the Treatment of Benign Prostatic Hyperplasia in Korean Men: 1-Year Randomized Open Label Study Editorial Comment
Kaplan, Steven A.
JOURNAL OF UROLOGY, 2016, 196 (02): : 503 - 503
[23] Re: Comparison of the Response to Treatment between Asian and Caucasian Men with Benign Prostatic Hyperplasia: Long-Term Results from the Combination of Dutasteride and Tamsulosin Study Editorial Comment
Kaplan, Steven A.
JOURNAL OF UROLOGY, 2014, 191 (02): : 423 - 424
[24] COMBINATION THERAPY WITH DUTASTERIDE AND TAMSULOSIN PROVIDED GREATER IMPROVEMENTS THAN EITHER MONOTHERAPY REGARDLESS OF PRIOR BENIGN PROSTATIC HYPERPLASIA OR LOWER URINARY TRACT TREATMENT STATUS
Siami, Paul
Damiao, Ronaldo
Montorsi, Francesco
Wilson, Timothy H.
Major-Walker, Kim
Gagnier, R. Paul
JOURNAL OF UROLOGY, 2010, 183 (04): : E692 - E692
[25] The Effects of Combination Therapy With Dutasteride and Tamsulosin on Clinical Outcomes in Men With Symptomatic Benign Prostatic Hyperplasia: 4-Year Results From the CombAT Study Editorial Comment
Kaplan, Steven A.
JOURNAL OF UROLOGY, 2011, 185 (04): : 1384 - +
[26] Fixed-dose combination vs monotherapy in first-line treatment of hypertension: A meta-analysis
Carvajal, A
Jabary, N
Del Pozo, JG
de Diego, IM
Martin, J
Delgadillo, J
JOURNAL OF HYPERTENSION, 2002, 20 : S244 - S244
[27] Treatment persistence with a fixed-dose combination of tadalafil (5 mg) and tamsulosin (0.4 mg) and reasons for early discontinuation in patients with benign prostatic hyperplasia and erectile dysfunction
Ahn, Sun Tae
Lee, Dong Hyun
Jeong, Hyeong Guk
Kim, Jong Wook
Oh, Mi Mi
Park, Hong Seok
Moon, Du Geon
INVESTIGATIVE AND CLINICAL UROLOGY, 2020, 61 (01) : 81 - 87
[28] PHARMACOECONOMIC ANALYSIS OF USING SOLIFENACIN AND MODIFIED-RELEASE TAMSULOSIN FIXED DOSE COMBINATION FOR TREATMENT OF STORAGE SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA
Avxentyev, N.
Frolov, M.
VALUE IN HEALTH, 2017, 20 (09) : A488 - A489
[29] Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind Combination of Avodart and Tamsulosin (CombAT) trial
Roehrborn, Claus G.
Barkin, Jack
Siami, Paul
Tubaro, Andrea
Wilson, Timothy H.
Morrill, Betsy B.
Gagnier, R. Paul
BJU INTERNATIONAL, 2011, 107 (06) : 946 - 954
[30] Efficacy and safety of a fixed-dose combination of dutasteride and tamsulosin treatment (Duodart®) compared with watchful waiting with initiation of tamsulosin therapy if symptoms do not improve, both provided with lifestyle advice, in the management of treatment-naive men with moderately symptomatic benign prostatic hyperplasia: 2-year CONDUCT study results
Roehrborn, Claus G.
Perez, Igor Oyarzabal
Roos, Erik P. M.
Calomfirescu, Nicolae
Brotherton, Betsy
Wang, Fang
Palacios, Juan Manuel
Vasylyev, Averyan
Manyak, Michael J.
BJU INTERNATIONAL, 2015, 116 (03) : 450 - 459

← 1 2 3 4 5 →